Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1462942
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1462942
Immune Cell Engineering Market, By Cell Type, By Product Type, By Disease Indication, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
PUBLISHED:
PAGES: 385 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Immune Cell Engineering Market size was valued at USD 2,922.5 Million in 2023, expanding at a CAGR of 20.5% from 2024 to 2032.
Immune cell engineering involves the modification of immune cells like T cells, NK cells, and dendritic cells for both research and therapeutic purposes. These applications range from the development of immunotherapies such as CAR T-cell therapy to the study of immune responses and drug discovery.
Immune Cell Engineering Market- Market Dynamics
Increasing demand for advanced cell therapies to propel market demand
The global market for immune cell engineering offers lucrative prospects for companies operating in the field, given the increasing demand for advanced cell therapies. Therapies employing engineered T cells or chimeric antigen receptor (CAR) T cells have demonstrated promising outcomes in clinical trials for cancer treatment. Key market drivers include significant investments in immunotherapies by major pharmaceutical firms and the expansion of clinical trials focusing on immune cell therapies. The ongoing progress in gene editing, cell isolation, and expansion technologies is substantially fueling the expansion of the immune cell engineering sector. The emergence of effective gene editing tools such as CRISPR/Cas9 has facilitated precise and safer alterations in immune cells. Concurrently, advancements in technologies like microfluidics and high-throughput assays are streamlining cell engineering processes. Moreover, the deepening comprehension of immune cell signaling pathways and interactions is empowering the development of more potent immune cell therapies. These continual technological advancements are anticipated to broaden the horizons and utility of engineered immune cells.
Immune Cell Engineering Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 20.5% over the forecast period (2024-2032)
Based on cell type segmentation, T cells was predicted to show maximum market share in the year 2023
Based on application segmentation, Cell Therapy & Regenerative Medicine was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
Immune Cell Engineering Market- Segmentation Analysis:
The Global Immune Cell Engineering Market is segmented on the basis of Cell Type, Product Type, Disease Indication, Application, and Region.
The market is divided into six categories based on Cell Type: T Cells, NK Cells, Dendritic Cells, Tumor Cells, Stem Cells, and others. In the Immune Cell Engineering market, T cells dominate among cell types. T cells are pivotal players in the immune system, possessing the capability to recognize and eliminate infected or cancerous cells. Their dominance stems from their versatile nature and crucial role in various immunotherapeutic approaches, particularly in CAR T-cell therapy. This therapy involves modifying T cells to express chimeric antigen receptors (CARs), enabling them to target and destroy cancer cells with precision. As CAR T-cell therapy gains traction in cancer treatment, the demand for engineered T cells continues to rise, driving their dominance in the market.
The market is divided into three categories based on application: Research Applications, Cell Therapy & Regenerative Medicine, and others. In terms of applications, Cell Therapy & Regenerative Medicine stands out as the dominating segment. This dominance is attributed to the transformative potential of immune cell engineering in developing novel cell-based therapies for various diseases. Cell therapy harnesses the therapeutic potential of engineered immune cells, such as T cells and stem cells, to treat cancer, autoimmune disorders, and regenerative medicine applications. CAR T-cell therapy, in particular, has revolutionized cancer treatment by offering personalized and targeted therapies with remarkable clinical outcomes. Additionally, the field of regenerative medicine utilizes engineered immune cells to repair and regenerate damaged tissues and organs, paving the way for innovative treatment approaches. The significant clinical success and broad therapeutic applications of immune cell-based therapies position Cell Therapy & Regenerative Medicine as the dominant application in the Immune Cell Engineering market.
Immune Cell Engineering Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Immune Cell Engineering Market- Competitive Landscape:
Immune cell engineering companies are adopting strategies focused on innovation, collaboration, and market expansion. They invest in research to enhance therapies like CAR T-cell therapy, forge partnerships for technology exchange, and expand into new markets. These efforts aim to address complexities in personalized therapy development, scale up production capacity, and reduce costs, ultimately aiming for broader patient access. Additionally, they leverage growing clinical evidence and partnerships to drive long-term market evolution in immune cell engineering.Recent Developments:
In August 2023, Astellas Pharma, Inc., a pharmaceutical company, and Poseida Therapeutics, a clinical-stage company, forged a strategic investment agreement to advance the development of cell therapies for cancer. Astellas committed a total of US$ 50 million, including a one-time US$ 25 million payment, to gain exclusive negotiation rights and first refusal to license one of Poseida's clinical-stage programs, P-MUC1C-ALLO1. This program focuses on developing an allogeneic chimeric antigen T cell (CAR-T) therapy for various solid tumor indications.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNE CELL ENGINEERING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
Thermo Fisher Scientific Inc.
Merck KGaA
Danaher Corporation
Lonza
Miltenyi Biotec
Takara Bio Inc.
Sartorius CellGenix GmbH
FUJIFILM Irvine Scientific
Agilent Technologies, Inc.
Bio-Techne
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company
Charles River Laboratories
Creative Bioarray
Sartorius AG
Novogene Co, Ltd.
AGC Biologics
Catalent, Inc.
WuXi AppTec
Others
GLOBAL IMMUNE CELL ENGINEERING MARKET, BY CELL TYPE - MARKET ANALYSIS, 2019 - 2032
- T Cells
- NK Cells
- Dendritic Cells
- Tumor Cells
- Stem Cells
- Others
GLOBAL IMMUNE CELL ENGINEERING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Consumables
- Instruments
- Software
GLOBAL IMMUNE CELL ENGINEERING MARKET, BY DISEASE INDICATION- MARKET ANALYSIS, 2019 - 2032
- Cardiovascular Diseases
- Respiratory Diseases
- Infectious Diseases
- Cancer
- Neurological Diseases
- Others
GLOBAL IMMUNE CELL ENGINEERING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Research Applications
- Cell Therapy & Regenerative Medicine
- Others
GLOBAL IMMUNE CELL ENGINEERING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV2400
Table of Contents
1.Immune Cell Engineering Market Overview
- 1.1.Study Scope
- 1.2.Market Estimation Years
2.Executive Summary
- 2.1.Market Snippet
- 2.1.1.Immune Cell Engineering Market Snippet by Cell Type
- 2.1.2.Immune Cell Engineering Market Snippet by Product Type
- 2.1.3.Immune Cell Engineering Market Snippet by Disease Indication
- 2.1.4.Immune Cell Engineering Market Snippet by Application
- 2.1.5.Immune Cell Engineering Market Snippet by Country
- 2.1.6.Immune Cell Engineering Market Snippet by Region
- 2.2.Competitive Insights
3.Immune Cell Engineering Key Market Trends
- 3.1.Immune Cell Engineering Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
- 3.2.Immune Cell Engineering Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
- 3.3.Immune Cell Engineering Market Opportunities
- 3.4.Immune Cell Engineering Market Future Trends
4.Immune Cell Engineering Industry Study
- 4.1.PEST Analysis
- 4.2.Porter's Five Forces Analysis
- 4.3.Growth Prospect Mapping
- 4.4.Regulatory Framework Analysis
5.Immune Cell Engineering Market: COVID-19 Impact Analysis
- 5.1.Pre-COVID-19 Impact Analysis
- 5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments
6.Immune Cell Engineering Market Landscape
- 6.1.Immune Cell Engineering Market Share Analysis, 2023
- 6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis
7.Immune Cell Engineering Market - By Cell Type
- 7.1.Overview
- 7.1.1.Segment Share Analysis, By Cell Type, 2023 & 2032 (%)
- 7.1.2.T Cells
- 7.1.3.NK Cells
- 7.1.4.Dendritic Cells
- 7.1.5.Tumor Cells
- 7.1.6.Stem Cells
- 7.1.7.Others
8.Immune Cell Engineering Market - By Product Type
- 8.1.Overview
- 8.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 8.1.2.Consumables
- 8.1.3.Instruments
- 8.1.4.Software
9.Immune Cell Engineering Market - By Disease Indication
- 9.1.Overview
- 9.1.1.Segment Share Analysis, By Disease Indication, 2023 & 2032 (%)
- 9.1.2.Cardiovascular Diseases
- 9.1.3.Respiratory Diseases
- 9.1.4.Infectious Diseases
- 9.1.5.Cancer
- 9.1.6.Neurological Diseases
- 9.1.7.Others
10.Immune Cell Engineering Market - By Application
- 10.1.Overview
- 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 10.1.2.Research Applications
- 10.1.3.Cell Therapy & Regenerative Medicine
- 10.1.4.Others
11.Immune Cell Engineering Market- By Geography
- 11.1.Introduction
- 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 11.2.North America
- 11.2.1.Overview
- 11.2.2.Immune Cell Engineering Key Manufacturers in North America
- 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4.North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.2.5.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.6.North America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.2.7.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8.U.S.
- 11.2.8.1.Overview
- 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.8.3.U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.2.8.4.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.8.5.U.S. Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.2.8.6.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9.Canada
- 11.2.9.1.Overview
- 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.9.3.Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.2.9.4.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.9.5.Canada Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.2.9.6.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.Europe
- 11.3.1.Overview
- 11.3.2.Immune Cell Engineering Key Manufacturers in Europe
- 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4.Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.3.5.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.6.Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.3.7.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8.Germany
- 11.3.8.1.Overview
- 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.8.3.Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.3.8.4.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.8.5.Germany Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.3.8.6.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9.Italy
- 11.3.9.1.Overview
- 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.9.3.Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.3.9.4.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.9.5.Italy Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.3.9.6.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10.United Kingdom
- 11.3.10.1.Overview
- 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.10.3.United Kingdom Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.3.10.4.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.10.5.United Kingdom Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.3.10.6.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11.France
- 11.3.11.1.Overview
- 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.11.3.France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.3.11.4.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.11.5.France Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.3.11.6.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12.Russia
- 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.12.2.Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.3.12.3.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.12.4.Russia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.3.12.5.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13.Netherlands
- 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.13.2.Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.3.13.3.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.13.4.Netherlands Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.3.13.5.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14.Sweden
- 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.14.2.Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.3.14.3.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.14.4.Sweden Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.3.14.5.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15.Poland
- 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.15.2.Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.3.15.3.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.15.4.Poland Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.3.15.5.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16.Rest of Europe
- 11.3.16.1.Overview
- 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.16.3.Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.3.16.4.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.16.5.Rest of the Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.3.16.6.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.Asia Pacific (APAC)
- 11.4.1.Overview
- 11.4.2.Immune Cell Engineering Key Manufacturers in Asia Pacific
- 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4.Asia Pacific Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.4.5.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.6.Asia Pacific Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.4.7.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8.India
- 11.4.8.1.Overview
- 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.8.3.India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.4.8.4.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.8.5.India Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.4.8.6.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9.China
- 11.4.9.1.Overview
- 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.9.3.China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.4.9.4.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.9.5.China Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.4.9.6.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10.Japan
- 11.4.10.1.Overview
- 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.10.3.Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.4.10.4.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.10.5.Japan Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.4.10.6.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11.South Korea
- 11.4.11.1.Overview
- 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.11.3.South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.4.11.4.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.11.5.South Korea Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.4.11.6.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12.Australia
- 11.4.12.1.Overview
- 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.12.3.Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.4.12.4.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.12.5.Australia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.4.12.6.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13.Thailand
- 11.4.13.1.Overview
- 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.13.3.Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.4.13.4.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.13.5.Thailand Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.4.13.6.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14.Indonesia
- 11.4.14.1.Overview
- 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.14.3.Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.4.14.4.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.14.5.Indonesia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.4.14.6.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15.Philippines
- 11.4.15.1.Overview
- 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.15.3.Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.4.15.4.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.15.5.Philippines Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.4.15.6.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16.Rest of APAC
- 11.4.16.1.Overview
- 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.16.3.Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.4.16.4.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.16.5.Rest of APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.4.16.6.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.Latin America
- 11.5.1.Overview
- 11.5.2.Immune Cell Engineering Key Manufacturers in Latin America
- 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4.Latin America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.5.5.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.6.Latin America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.5.7.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8.Brazil
- 11.5.8.1.Overview
- 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.8.3.Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.5.8.4.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.8.5.Brazil Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.5.8.6.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9.Mexico
- 11.5.9.1.Overview
- 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.9.3.Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.5.9.4.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.9.5.Mexico Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.5.9.6.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10.Argentina
- 11.5.10.1.Overview
- 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.10.3.Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.5.10.4.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.10.5.Argentina Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.5.10.6.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11.Colombia
- 11.5.11.1.Overview
- 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.11.3.Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.5.11.4.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.11.5.Colombia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.5.11.6.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12.Rest of LATAM
- 11.5.12.1.Overview
- 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.12.3.Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.5.12.4.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.12.5.Rest of LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.5.12.6.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.Middle East and Africa
- 11.6.1.Overview
- 11.6.2.Immune Cell Engineering Key Manufacturers in Middle East and Africa
- 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4.Middle East and Africa Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.6.5.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.6.Middle East and Africa Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.6.7.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8.Saudi Arabia
- 11.6.8.1.Overview
- 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.8.3.Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.6.8.4.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.8.5.Saudi Arabia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.6.8.6.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9.United Arab Emirates
- 11.6.9.1.Overview
- 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.9.3.United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.6.9.4.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.9.5.United Arab Emirates Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.6.9.6.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10.Israel
- 11.6.10.1.Overview
- 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.10.3.Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.6.10.4.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.10.5.Israel Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.6.10.6.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11.Turkey
- 11.6.11.1.Overview
- 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.11.3.Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.6.11.4.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.11.5.Turkey Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.6.11.6.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12.Algeria
- 11.6.12.1.Overview
- 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.12.3.Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.6.12.4.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.12.5.Algeria Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.6.12.6.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13.Egypt
- 11.6.13.1.Overview
- 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.13.3.Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.6.13.4.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.13.5.Egypt Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.6.13.6.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14.Rest of MEA
- 11.6.14.1.Overview
- 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.14.3.Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.6.14.4.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.14.5.Rest of MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
- 11.6.14.6.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.Key Vendor Analysis- Immune Cell Engineering Industry
- 12.1.Competitive Dashboard
- 12.2.Company Profiles
- 12.2.1.Thermo Fisher Scientific Inc.
- 12.2.2.Merck KGaA
- 12.2.3.Danaher Corporation
- 12.2.4.Lonza
- 12.2.5.Miltenyi Biotec
- 12.2.6.Takara Bio Inc.
- 12.2.7.Sartorius CellGenix GmbH
- 12.2.8.FUJIFILM Irvine Scientific
- 12.2.9.Agilent Technologies, Inc.
- 12.2.10.Bio-Techne
- 12.2.11.Bio-Rad Laboratories, Inc.
- 12.2.12.Becton, Dickinson and Company
- 12.2.13.Charles River Laboratories
- 12.2.14.Creative Bioarray
- 12.2.15.Sartorius AG
- 12.2.16.Novogene Co, Ltd.
- 12.2.17.AGC Biologics
- 12.2.18.Catalent, Inc.
- 12.2.19.WuXi AppTec
- 12.2.20.Others
13.360 Degree Analyst View
14.Appendix
- 14.1.Research Methodology
- 14.2.References
- 14.3.Abbreviations
- 14.4.Disclaimer
- 14.5.Contact Us
Product Code: ANV2400
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Immune Cell Engineering Market: Cell Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Cell Type
- TABLE Global Immune Cell Engineering Market, by Cell Type 2019-2032 (USD Million)
- TABLE Immune Cell Engineering Market: Product Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Product Type
- TABLE Global Immune Cell Engineering Market, by Product Type 2019-2032 (USD Million)
- TABLE Immune Cell Engineering Market: Disease Indication Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Disease Indication
- TABLE Global Immune Cell Engineering Market, by Disease Indication 2019-2032 (USD Million)
- TABLE Immune Cell Engineering Market: Application Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Immune Cell Engineering Market, by Application 2019-2032 (USD Million)
- TABLE Immune Cell Engineering Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Immune Cell Engineering Market, by Region 2019-2032 (USD Million)
- TABLE North America Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
- TABLE North America Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
- TABLE North America Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
- TABLE North America Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
- TABLE North America Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)
- TABLE Europe Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
- TABLE Europe Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
- TABLE Europe Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
- TABLE Europe Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
- TABLE Europe Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)
- TABLE Asia Pacific Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
- TABLE Asia Pacific Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
- TABLE Asia Pacific Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
- TABLE Asia Pacific Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)
- TABLE Latin America Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
- TABLE Latin America Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
- TABLE Latin America Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
- TABLE Latin America Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.